EDITION OF SUN 27 SEP 2026
114 · BUSINESS

FDA Raises Thyroid Drug Recall to Highest Risk Level as Blood Pressure Medicine Is Recalled

publishers 15articles 16first reported 24 Sep, 12:18 UTCdeveloping since 24 Sep · 6 editions

The Food and Drug Administration has elevated a recall of thyroid medication to its highest risk classification, according to reports from USA Today, NewsNation and News4JAX.

Separately, more than 13,000 bottles of a blood pressure medication have been recalled nationwide, according to EatingWell, WSB-TV, The Healthy and Health.com. Daily Voice also reported a major nationwide drug recall alert.

HOW THIS STORY WAS MADE

Written from 8 articles, headlines and summaries only; 8 independent newsrooms once syndicated copies count as one; this version written within the hour the record first saw the story; the editor kept it as written.

Publishers
15
Source articles
16
Given to the writer
8, headlines and summaries only
Independent newsrooms
8
This version written
within the hour the record first saw the story
Second model (editor)
kept as written
Publication gate
passed
Human review
none

Written by a language model from the sources above, then checked by a second model that may only cut, attribute or correct. How it works →

NAMED IN THE COVERAGE

OUTLETS CARRYING THE STORY, RUN BY RUN

0 8 17 25 Sep 26 Sep 27 Sep 28 Sep 29 Sep 25 Sep 00:18 UTC · FDA Raises Thyroid Drug Recall to Highest Risk Level as Blood Pressure Medicine Is Recalled

WHAT HELD, WHAT CAME LATER

From the first reports to the latest

  • Nothing ran from the first third of the coverage to the last.

Entered the story later

  • Nothing new took hold after the first third.

HOW THIS STORY DEVELOPED: EVERY HEADLINE, EVERY OUTLET →